APA (7th ed.) Citation

Krohmer, E., Rohr, B. S., Stoll, F. E., Gümüs, K. S., Bergamino, M., Mikus, G., . . . Haefeli, W. E. (2025). Influence of a short course of ritonavir used as booster in antiviral therapies against SARS-CoV-2 on the exposure of atorvastatin and rosuvastatin. Cardiovascular drugs and therapy, 39, . https://doi.org/10.1007/s10557-023-07538-w

Chicago Style (17th ed.) Citation

Krohmer, Evelyn, et al. "Influence of a Short Course of Ritonavir Used as Booster in Antiviral Therapies Against SARS-CoV-2 on the Exposure of Atorvastatin and Rosuvastatin." Cardiovascular Drugs and Therapy 39 (2025). https://doi.org/10.1007/s10557-023-07538-w.

MLA (9th ed.) Citation

Krohmer, Evelyn, et al. "Influence of a Short Course of Ritonavir Used as Booster in Antiviral Therapies Against SARS-CoV-2 on the Exposure of Atorvastatin and Rosuvastatin." Cardiovascular Drugs and Therapy, vol. 39, 2025, https://doi.org/10.1007/s10557-023-07538-w.